CYCLO SPRAY, 2.45 % W/W FOR CATTLE, SHEEP AND PIGS

国家: 爱尔兰

语言: 英文

来源: HPRA (Health Products Regulatory Authority)

有效成分:

CHLORTETRACYCLINE HYDROCHLORIDE PH.EUR. (EQUIVALENT TO 2.45% W/W)

可用日期:

Eurovet Animal Health B.V.

ATC代码:

QD06A

INN（国际名称）:

CHLORTETRACYCLINE HYDROCHLORIDE PH.EUR. (EQUIVALENT TO 2.45% W/W)

剂量:

2.45 %w/w

药物剂型:

Cutaneous Spray, suspension

处方类型:

POM

治疗组:

Bovine, Ovine, Porcine

治疗领域:

ANTIBIOTICS FOR TOPICAL USE

疗效迹象:

Antibacterial

授权状态:

Authorised

授权日期:

2001-03-23

产品特点

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Cyclo Spray, 2.45 % w/w for cattle, sheep and pigs.
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
3 PHARMACEUTICAL FORM
Cutaneous Spray, Suspension.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Cattle, sheep and pigs.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
•
Treatment of superficial traumatic or surgical wounds contaminated
with chlortetracycline-sensitive agents.
•
The product can be used as part of a treatment for superficial skin
and claw/hoof infections, in particular
interdigital dermatitis (foot rot and foul in the foot) and digital
dermatitis caused by micro-organisms sensitive to
chlortetracycline.
Per container of 270 mL:
ACTIVE SUBSTANCE:
Chlortetracycline HCl.
The active ingredient content is 2.45 % w/w
(equivalent to 3.210 g)
EXCIPIENTS:
Patent Blue V (E 131)
0.15 % w/w (equivalent to 0.196 g)
Butane 100
68.77% w/w(equivalent to 89.920g)
Per container of 520 mL:
ACTIVE SUBSTANCE:
Chlortetracycline HCl.
The active ingredient content is 2.45 % w/w (equivalent to 6.420 g)
EXCIPIENTS:
Patent Blue V (E 131)
0.15 % w/w (equivalent to 0.392 g)
Butane 100
68.77%w/w(equivalent to 179.840g)
For a full list of excipients, see section 6.1.
H
E
A
L
T
H
P
R
O
D
U
C
T
S
R
E
G
U
L
A
T
O
R
Y
A
U
T
H
O
R
I
T
Y
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_D_
_a_
_t_
_e_
_ _
_P_
_r_
_i_
_n_
_t_
_e_
_d_
_ _
_2_
_5_
_/_
_0_
_1_
_/_
_2_
_0_
_1_
_7_
_C_
_R_
_N_
_ _
_7_
_0_
_2_
_5_
_4_
_9_
_4_
_p_
_a_
_g_
_e_
_ _
_n_
_u_
_m_
_b_
_e_
_r_
_:_
_ _
_1_
4.3 CONTRAINDICATIONS
Do not use in case of hypersensitivity to tetr